Incomplete stent apposition after coronary stent implantation: Myth or reality?

Journal of Interventional Cardiology

Volumn 22, Issue 4, 2009, Pages 341-349

  Rathore, Sudhir ^a   Terashima, Mitsuyasu ^a   Habara, M ^a   Kinoshita, Yoshihisa ^a   Nasu, Kenya ^a   Katoh, Osamu ^a   Suzuki, Takahiko ^a  

^a Toyohashi Heart Center Toyohashi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; PREDNISOLONE; RAPAMYCIN; ZOTAROLIMUS; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTERY INTIMA PROLIFERATION; BARE METAL STENT; CLINICAL TRIAL; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; INCIDENCE; INCOMPLETE STENT APPOSITION; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STENT THROMBOSIS; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; INTERVENTION STUDY; RISK;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTERVENTION STUDIES; ODDS RATIO; PACLITAXEL; RISK FACTORS; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 68849100613     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00485.x     Document Type: Review

References (48)

1. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional ultrasound study. Circulation 2001 1003 : 192 195.
2. Morrice MC, Serruys PW, Sousa JE, et al., RAVEL Study Group. Randomised study with the sirolimus-coated B× velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomised comparison of a sirolimus eluting stent with a standard stent for coronary revascularisation. N Engl J Med 2002 346 : 1773 1780.
3. Moses JW, Leon MB, Popma JJ, et al., Sirius Investigators. Sirolimus eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323.
4. Stone GW, Ellis SG, Cox DA, et al., TAXUS-IV Investigators. A polymer based, paclitaxel eluting stent in patients with coronary artery disease. N Engl J Med 2004 350 : 221 231.
5. Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug eluting stents. Lancet 2004 364 : 583 591.
6. Costa MA, Sabat M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachtherapy. Circulation 1999 100 : 789 792.
7. Waksman R. Late thrombosis after radiation: Sitting on a time bomb. Circulation 1999 100 : 78 82.
8. Morino Y, Bonneau HN, Fitzgerald PJ. Vascular brachytherapy: What have we learned from intravascular ultrasound? J Invasive Cardiol 2001 13 : 409 416.
9. Mintz GS, Weissman NJ, Fitzgerald PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation 2001 104 : 1320 1325.
10. Guagliumi G, Virmani R, Musumeci G, et al. Drug eluting versus bare metal coronary stents: Long term human pathology. Finding from different coronary arteries in the same patient. Ital Heart J 2003 4 : 713 720.
11. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus or paclitaxel eluting stents. Circulation 2005 112 : 270 278.
12. Virmani R, Gaugliumi G, Farb A, et al. Localised hypersensitivity and late coronary thrombosis secondary to a sirolimus eluting stent: Should we be cautious? Circulation 2004 109 : 701 705.
13. Degertekin M, Serruys PW, Tanabe K, et al. Long term follow up of incomplete stent apposition in patients who received the sirolimus eluting stent for de-novo coronary lesions: An intravascular ultrasound analysis. Circulation 2003 108 : 2747 2750.
14. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004 364 : 1519 1521. (Pubitemid 39410418)
15. Fajadet J, Wijns W, Laarman GJ, et al., ENDEAVOR II Investigators. Randomised, double blind, multicenter study of the Endeavour zotarolimus eluting phosphorylcholine-encapsulated stent for the treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial.
16. Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis events with drug eluting stents. J Am Coll Cardiol 2005 45 : 2088 2092.
17. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug eluting stent implantation. Circulation 2007 115 : 2426 2434.
18. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel eluting stents. Circulation 2006 113 : 1108 1113.
19. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluting stents. JAMA 2005 293 : 2126 2130.
20. Joner M, Finn AV, Farb A, et al. Pathology of drug eluting stents in humans. J Am Coll Cardiol 2006 48 : 193 202.
21. Weissman NJ, Ellis SG, Grube E, et al. Effect of the polymer based, paclitaxel-eluting TAXUS express stent on vascular tissue responses: A volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 2007 28 : 1574 1582.
22. Tanabe K, Serruys PW, Degertekin M, et al., TAXUS II Study Group. Incomplete stent apposition after implantation of paclitaxel eluting stents or bare metal stents: Insights from the randomised TAXUS II trial. Circulation 2005 11 : 900 905.
23. Hong MK, Mintz GS, Lee WC, et al. Paclitaxel coating reduces in stent intimal hyperplasia in human coronary arteries: A serial volumetric intravascular ultrasound analysis from the Asian paclitaxel eluting stent clinical trial. Circulation 2003 107 : 517 520.
24. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus eluting stent implantation: A serial intravascular ultrasound analysis. J Am Coll Cardiol 2005 46 : 1002 5.
25. Hoffmann R, Morice MC, Moses JW, et al. Impact of late incomplete stent apposition after sirolimus eluting stent implantation on 4 year clinical events: Intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart 2007 94 : 322 328.
26. Quevedo PJ, Sbate M, Angiolillo DJ, et al. Vascular effects of sirolimus eluting versus bare metal stents in diabetic patients: Three dimensional ultrasound results of the diabetes and sirolimus eluting stents (DIABETES) trial. J Am Coll Cardiol. 2006 47 : 2172 2179.
27. van der Hoeven BL, Liem SS, Jukema W, et al. Sirolimus eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION Intervention Study. J Am Coll Cardiol 2008 51 : 718 26.
28. Siqueira DA, Abizaid AA, Costa JD, et al. Late incomplete apposition after drug eluting stent implantation: Incidence and potential for adverse clinical outcomes. Eur Heart J 2007 28 : 1304 1309.
29. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug eluting stent implantation: An intravascular ultrasound analysis with long term follow up. Circulation 2006 113 (3 414 9. Am J Cardiol. 2006;98:464-469.
30. Tsuchiya Y, Lansky AJ, Costa RA, et al. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
31. Miyazawa A, Ako J, Hongo Y, et al., the ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus eluting stent versus sirolimus eluting stent: Intravascular ultrasound results from ENDEAVOR III. Am Heart J 2008 155 : 108 113.
32. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004 109 (7 881 886.
33. Feres F, Costa JR Jr., Abizaid A. Very late thrombosis after drug eluting stents. Catheter Cardiovasc Interv 2006 68 : 83 88.
34. Chen BX, Ma FY, Luo W, et al. Neointimal coverage of bare metal and sirolimus eluting stents evaluated with optical coherence tomography. Heart 2008 94 : 566 570.
35. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus eluting stents at 6 months follow up: Evaluated by optical coherence tomography. Eur Heart J 2007 28 : 961 967.
36. Bourma BE, Tearney GJ, Yabushita H, et al. Evaluation of intra-coronary stenting by intravascular optical coherence tomography. Heart 2003 89 : 317 320.
37. Tanigawa J, Barlis P, Kaplan S, et al. Stent strut apposition in complex lesions using optical coherence tomography. Am J Cardiol 2006 98 (Suppl. 1 TCT 231.
38. Shinke T, Jinsheng L, Jack P, et al. High incidence of intramural thrombus after overlapping paclitaxel eluting stent implantation: Angioscopic and histopathological analysis in porcine coronary arteries. Circ Cardiovasc Intervent 2008 1 : 28 35.
39. Ribichini F, Joner M, Ferrero V, et al. Effects of oral prednisolone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol 2007 50 : 176 185.
40. Shah V, Mintz GS, Apple S, et al. Background Incidence of late malapposition after bare metal stent implantation. Circulation 2002 106 : 1753 1755.
41. Mintz GS, Shah VM, Weissman NJ. Regional remodelling as the cause of late stent malapposition. Circulation 2003 107 : 2660 2663.
42. Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002 23 : 124 132.
43. Bliden KP, DiChiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: Is the current antiplatelet therapy adequate? J Am Coll Cardiol 2007 49 : 657 666.
44. Nibeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug eluting stents: A review of available cases from the research on adverse drug events and reports (RADAR) project. J Am Coll Cardiol 2006 47 : 175 181.
45. Kounis NG, Hahalis GN, Theoharides TC. Coronary stents, hypersensitivity reactions, and the Kounis syndrome. J Interv Cardiol 2007 20 : 314 323.
46. Chechi T, Vittori G, Biondi Zoccai GG, et al. Single center randomised evaluation of paclitaxel eluting stent versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 2007 : 20 : 282 291.
47. Nakamura M, Yock PG, Bonneau HN, et al. Impact of peri stent remodelling on restenosis: A volumetric intravascular ultrasound study. Circulation 2001 103 : 2130 2132.
48. Waseda K, Ako J, Yamasaki M, et al. Impact of polymer formulations on neointimal proliferations following zotarolimus eluting stent with a different polymer: Results of 3D intravascular ultrasound analysis. Circulation 2007 116 : II-615.